Related Experiment Video
Updated: May 31, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection
Yongwen Chen1, Shengxi Wu, Guoning Guo
1Institute of Immunology, PLA, Third Military Medical University, Chongqing, P. R. China.
Abstract:
The inhibitory receptor programmed death-1 (PD-1) has the capacity to maintain peripheral tolerance and limit immunopathological damage; however, its precise role in fulminant viral hepatitis (FH) has yet to be described. Here, we investigated the functional mechanisms of PD-1 as related to FH pathogenesis induced by the murine hepatitis virus strain-3 (MHV-3). High levels of PD-1-positive CD4(+), CD8(+) T cells, NK cells and macrophages were observed in liver, spleen, lymph node and thymus tissues following MHV-3 infection. PD-1-deficient mice exhibited significantly higher expression of the effector molecule which initiates fibrinogen deposition, fibrinogen-like protein 2 (FGL2), than did their wild-type (WT) littermates. As a result, more severe tissue damage was produced and mortality rates were higher. Fluorescence double-staining revealed that FGL2 and PD-1 were not co-expressed on the same cells, while quantitative RT-PCR demonstrated that higher levels of IFN-γ and TNF-α mRNA transcription occurred in PD-1-deficient mice in response to MHV-3 infection. Conversely, in vivo blockade of IFN-γ and TNF-α led to efficient inhibition of FGL2 expression, greatly attenuated the development of tissue lesions, and ultimately reduced mortality. Thus, the up-regulation of FGL2 in PD-1-deficient mice was determined to be mediated by IFN-γ and TNF-α. Taken together, our results suggest that PD-1 signaling plays an essential role in decreasing the immunopathological damage induced by MHV-3 and that manipulation of this signal might be a useful strategy for FH immunotherapy.
Insights
Programmed death-1 (PD-1) signaling limits liver damage in fulminant viral hepatitis (FH). PD-1 deficiency increases fibrinogen-like protein 2 (FGL2) via IFN-γ and TNF-α, worsening FH. Manipulating PD-1 may treat FH.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Programmed death-1 (PD-1) is crucial for peripheral tolerance and limiting immune-mediated damage.
- Its role in fulminant viral hepatitis (FH) pathogenesis remains unclear.
Purpose of the Study:
- To investigate the functional mechanisms of PD-1 in FH induced by murine hepatitis virus strain-3 (MHV-3).
- To elucidate the role of PD-1 signaling in regulating immunopathological damage during MHV-3 infection.
Main Methods:
- Analysis of PD-1 expression on immune cells in various tissues post-MHV-3 infection.
- Comparison of FH severity and fibrinogen-like protein 2 (FGL2) expression in PD-1-deficient and wild-type mice.
- Assessment of IFN-γ and TNF-α mRNA levels and the effect of their blockade on FGL2 expression and FH pathology.
Main Results:
- High PD-1 expression was observed on CD4(+), CD8(+) T cells, NK cells, and macrophages in infected tissues.
- PD-1-deficient mice showed significantly elevated FGL2 expression, leading to more severe liver damage and higher mortality.
- FGL2 upregulation in PD-1-deficient mice was mediated by increased IFN-γ and TNF-α, and blocking these cytokines attenuated FH pathology.
Conclusions:
- PD-1 signaling plays a critical role in mitigating immunopathological damage during MHV-3-induced FH.
- The protective effect of PD-1 involves suppressing IFN-γ and TNF-α, thereby limiting FGL2-mediated liver injury.
- Targeting PD-1 signaling represents a potential therapeutic strategy for FH immunotherapy.

